Legency Remedies Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 23-10-2024
- Paid Up Capital ₹ 9.30 M
as on 23-10-2024
- Company Age 19 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 62.00 Cr
as on 23-10-2024
- Satisfied Charges ₹ 29.26 Cr
as on 23-10-2024
- Revenue 20.75%
(FY 2023)
- Profit 368.21%
(FY 2023)
- Ebitda 165.55%
(FY 2023)
- Net Worth 42.76%
(FY 2023)
- Total Assets 50.39%
(FY 2023)
About Legency Remedies
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 9.30 M.
The company currently has active open charges totaling ₹62.00 Cr. The company has closed loans amounting to ₹29.26 Cr, as per Ministry of Corporate Affairs (MCA) records.
Manoj Jain, Raman Goyal, and Ravi Goyal serve as directors at the Company.
- CIN/LLPIN
U24230HP2005PTC030847
- Company No.
030847
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Feb 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Himachal Pradesh
Industry
Company Details
- Location
Solan, Himachal Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Legency Remedies Private Limited offer?
Legency Remedies Private Limited offers a wide range of products and services, including Common Disease Medicines, Injectable Products, IV Fluids, Mineral Supplement, Ferrous Ascorbate Tablet, Antihistamines, Phenylephrine Hcl Tablet, Anti Asthma Drug, Respules, Asthma Inhaler.
Who are the key members and board of directors at Legency Remedies?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manoj Jain  | Director | 11-Jul-2007 | Current |
| Raman Goyal | Director | 11-Jul-2007 | Current |
| Ravi Goyal | Director | 19-Aug-2016 | Current |
Financial Performance of Legency Remedies.
Legency Remedies Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 20.75% increase. The company also saw a substantial improvement in profitability, with a 368.21% increase in profit. The company's net worth Soared by an impressive increase of 42.76%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Legency Remedies?
In 2023, Legency Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 11 May 2024 | ₹37.47 Cr | Open |
Axis Bank Limited Creation Date: 22 Dec 2023 | ₹4.00 Cr | Open |
Hdfc Bank Limited Creation Date: 25 May 2023 | ₹3.50 M | Open |
How Many Employees Work at Legency Remedies?
Legency Remedies has a workforce of 73 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Legency Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Legency Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
